Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v16-EN
Language French English
Date Updated 2019-07-03 2019-06-10
Drug Identification Number 00721891 00721891
Brand name EPINEPHRINE INJECTION USP EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHRINE INJECTION USP EPINEPHRINE INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients EPINEPHRINE EPINEPHRINE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRACARDIAC INTRAMUSCULAR INTRATRACHEAL INTRAVENOUS SUBCUTANEOUS INTRACARDIAC INTRAMUSCULAR INTRATRACHEAL INTRAVENOUS SUBCUTANEOUS
Packaging size 50 x 1mL AMP 50 x 1mL AMP
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-30 2018-11-30
Estimated end date 2019-06-14
Actual end date 2019-07-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Inventory is on preventative allocation.
Health Canada comments